KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Interest Coverage Ratio (2018 - 2020)

Xenon Pharmaceuticals (XENE) has disclosed Interest Coverage Ratio for 4 consecutive years, with 4.19 as the latest value for Q2 2020.

  • On a quarterly basis, Interest Coverage Ratio rose 85.43% to 4.19 in Q2 2020 year-over-year; TTM through Mar 2021 was 255.37, a 2810.62% decrease, with the full-year FY2020 number at 64.67, down 725.3% from a year prior.
  • Interest Coverage Ratio was 4.19 for Q2 2020 at Xenon Pharmaceuticals, up from 24.34 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 52.72 in Q4 2019 to a low of 49.09 in Q1 2018.
  • A 3-year average of 15.35 and a median of 24.34 in 2020 define the central range for Interest Coverage Ratio.
  • Biggest YoY gain for Interest Coverage Ratio was 85.43% in 2020; the steepest drop was 25.88% in 2020.
  • Xenon Pharmaceuticals' Interest Coverage Ratio stood at 20.92 in 2018, then skyrocketed by 351.95% to 52.72 in 2019, then tumbled by 107.96% to 4.19 in 2020.
  • Per Business Quant, the three most recent readings for XENE's Interest Coverage Ratio are 4.19 (Q2 2020), 24.34 (Q1 2020), and 52.72 (Q4 2019).